{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:51:13Z","timestamp":1793677873181,"version":"4.5.1"},"reference-count":207,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F&#x00F6;rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.drudis.2020.10.009","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T11:43:36Z","timestamp":1603280616000},"page":"122-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Advances in the development of entry inhibitors for sialic-acid-targeting viruses"],"prefix":"10.1016","volume":"26","author":[{"given":"Rick","family":"Heida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshita C.","family":"Bhide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Gasbarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zg\u00fcn","family":"Kocabiyik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Stellacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke L.W.","family":"Huckriede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter L.J.","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henderik W.","family":"Frijlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2020.10.009_bib0005","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1098\/rstb.2011.0354","article-title":"Human viruses: discovery and emergence","volume":"367","author":"Woolhouse","year":"2012","journal-title":"Philos. Trans. R. Soc. B"},{"key":"10.1016\/j.drudis.2020.10.009_bib0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.drudis.2020.10.009_bib0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.molmed.2008.06.002","article-title":"Sialic acids in human health and disease","volume":"14","author":"Varki","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.drudis.2020.10.009_bib0020","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nature05816","article-title":"Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins","volume":"446","author":"Varki","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2020.10.009_bib0025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1098\/rspb.1982.0022","article-title":"Effect of removing sialic acids from endothelium on the adherence of circulating platelets in arteries in vivo","volume":"214","author":"Gorog","year":"1982","journal-title":"Proc. R. Soc. Lond. B"},{"key":"10.1016\/j.drudis.2020.10.009_bib0030","first-page":"907","article-title":"In vivo enzymatic removal of alpha 2-->6-linked sialic acid from the glomerular filtration barrier results in podocyte charge alteration and glomerular injury","volume":"74","author":"Gelberg","year":"1996","journal-title":"Lab. Invest."},{"key":"10.1016\/j.drudis.2020.10.009_bib0035","first-page":"543","article-title":"Unusually high concentrations of sialic acids on the surface of vascular endothelia","volume":"66","author":"Born","year":"1985","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0040","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cub.2010.09.061","article-title":"Electrostatic cell-surface repulsion initiates lumen formation in developing blood vessels","volume":"20","author":"Strili\u0107","year":"2010","journal-title":"Curr. Biol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0045","doi-asserted-by":"crossref","DOI":"10.3945\/an.112.001875","article-title":"Molecular mechanism underlying sialic acid as an essential nutrient for brain development and cognition","volume":"3","author":"Wang","year":"2012","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.drudis.2020.10.009_bib0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A","article-title":"The polysialic acid modification of the neural cell adhesion molecule is involved in spatial learning and hippocampal long-term potentiation","volume":"45","author":"Becker","year":"1996","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.drudis.2020.10.009_bib0055","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.tim.2016.07.005","article-title":"Effects of sialic acid modifications on virus binding and infection","volume":"24","author":"Wasik","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1021\/cr000407m","article-title":"Chemical diversity in the sialic acids and related \u03b1-keto acids: an evolutionary perspective","volume":"102","author":"Angata","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/j.drudis.2020.10.009_bib0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/bs.accb.2018.09.004","article-title":"Sialic acids in nonenveloped virus infections","volume":"76","author":"Blaum","year":"2019","journal-title":"Adv. Carbohydr. Chem. Biochem"},{"key":"10.1016\/j.drudis.2020.10.009_bib0070","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.celrep.2015.05.044","article-title":"Complexity and diversity of the mammalian sialome revealed by nidovirus virolectins","volume":"11","author":"Langereis","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.drudis.2020.10.009_bib0075","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ajpa.10018","article-title":"Loss of N-glycolylneuraminic acid in humans: mechanisms, consequences, and implications for hominid evolution","volume":"116","author":"Varki","year":"2001","journal-title":"Am. J. Phys. Anthropol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.nutr.28.061807.155515","article-title":"Sialic acid is an essential nutrient for brain development and cognition","volume":"29","author":"Wang","year":"2009","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.drudis.2020.10.009_bib0085","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrmicro3346","article-title":"The sweet spot: defining virus\u2013sialic acid interactions","volume":"12","author":"Stencel-Baerenwald","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/296115a0","article-title":"Molecular mechanisms of variation in influenza viruses","volume":"296","author":"Webster","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2020.10.009_bib0095","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3389\/fimmu.2018.01946","article-title":"Treating InfluenzaInfection, From Now and Into the Future","volume":"9","author":"Davidson","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5485","article-title":"The 1918 influenza pandemic: 100 years of questions answered and unanswered","volume":"11","author":"Taubenberger","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drudis.2020.10.009_bib0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev.pathmechdis.3.121806.154316","article-title":"The pathology of influenza virus infections","volume":"3","author":"Taubenberger","year":"2008","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0110","first-page":"69","article-title":"Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs","volume":"55","author":"Gasparini","year":"2014","journal-title":"J. Prev. Med. Hyg."},{"key":"10.1016\/j.drudis.2020.10.009_bib0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/viro.1997.8572","article-title":"Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6\u2032-sialyl(N-ace","volume":"232","author":"Gambaryan","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2020.10.009_bib0120","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1128\/JVI.72.9.7367-7373.1998","article-title":"Molecular basis for the generation in pigs of influenza A viruses with pandemic potential","volume":"72","author":"Ito","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0042-6822(83)90150-2","article-title":"Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin","volume":"127","author":"Rogers","year":"1983","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2020.10.009_bib0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1348-0421.2000.tb02516.x","article-title":"Interspecies transmission and receptor recognition of influenza A viruses","volume":"44","author":"Ito","year":"2000","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0135","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2018.01581","article-title":"Influenza A virus cell entry, replication, virion assembly and movement","volume":"9","author":"Dou","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1099\/vir.0.059477-0","article-title":"Entry of influenza A virus: host factors and antiviral targets","volume":"95","author":"Edinger","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0145","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0042-6822(66)90178-4","article-title":"Functional significance of sialidose during influenza virus multiplication","volume":"30","author":"Seto","year":"1966","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2020.10.009_bib0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/vaccines6020028","article-title":"Immune history and influenza vaccine effectiveness","volume":"6","author":"Lewnard","year":"2018","journal-title":"Vaccines"},{"key":"10.1016\/j.drudis.2020.10.009_bib0155","series-title":"Expert Opinion on Neuraminidase Inhibitors for the Prevention and Treatment of Influenza. Review of Recent Systematic Reviews and Meta-Analyses","author":"European Centre for Disease Prevention and Control","year":"2017"},{"key":"10.1016\/j.drudis.2020.10.009_bib0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41564-019-0609-0","article-title":"Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets","volume":"5","author":"Imai","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41564-019-0639-7","article-title":"Emerging antiviral resistance","volume":"5","author":"Kormuth","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0170","first-page":"346","article-title":"Treatment-emergent influenza variant viruses with reduced baloxavir susceptibility: impact on clinical and virologic outcomes in uncomplicated influenza","volume":"221","author":"Uehara","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0175","first-page":"367","article-title":"Replicative fitness of seasonal influenza A viruses with decreased susceptibility to baloxavir","volume":"221","author":"Chesnokov","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0180","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/cid\/ciz911","article-title":"Resistance of influenza virus to antiviral medications","volume":"71","author":"Whitley","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0185","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3389\/fmicb.2018.01826","article-title":"The cranberry extract Oximacro\u00ae exerts in vitro virucidal activity against influenza virus by interfering with hemagglutinin","volume":"9","author":"Luganini","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0190","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.1801999115","article-title":"A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin","volume":"115","author":"Kadam","year":"2018","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.drudis.2020.10.009_bib0195","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41598-020-57608-4","article-title":"Antiviral potential of 3\u2032-sialyllactose- and 6\u2032-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses","volume":"10","author":"G\u00fcnther","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2020.10.009_bib0200","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1021\/acs.molpharmaceut.0c00244","article-title":"Synthesis of a hexavalent betulinic acid derivative as a hemagglutinin-targeted influenza virus entry inhibitor","volume":"17","author":"Chen","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.drudis.2020.10.009_bib0205","doi-asserted-by":"crossref","first-page":"104782","DOI":"10.1016\/j.antiviral.2020.104782","article-title":"Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus","volume":"177","author":"Hussein","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.drudis.2020.10.009_bib0210","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1021\/acs.jmedchem.9b01900","article-title":"Optimization of 4-aminopiperidines as inhibitors of influenza A viral entry that are synergistic with oseltamivir","volume":"63","author":"Gaisina","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2020.10.009_bib0215","doi-asserted-by":"crossref","first-page":"112223","DOI":"10.1016\/j.ejmech.2020.112223","article-title":"N-benzyl 4,4-disubstituted piperidines as a potent class of influenza H1N1 virus inhibitors showing a novel mechanism of hemagglutinin fusion peptide interaction","volume":"194","author":"de Castro","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.drudis.2020.10.009_bib0220","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/v12020225","article-title":"An oleanolic acid derivative inhibits hemagglutinin-mediated entry of influenza A virus","volume":"12","author":"Ye","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2020.10.009_bib0225","doi-asserted-by":"crossref","first-page":"115130","DOI":"10.1016\/j.bmc.2019.115130","article-title":"Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones","volume":"28","author":"Cihan-\u00dcst\u00fcnda\u011f","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2020.10.009_bib0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159074","article-title":"Anti-hemagglutinin antibody derived lead peptides for inhibitors of influenza virus binding","volume":"11","author":"Memczak","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2020.10.009_bib0235","doi-asserted-by":"crossref","first-page":"12417","DOI":"10.1002\/anie.202006145","article-title":"Adaptive flexible sialylated nanogels as highly potent influenza A virus inhibitors","volume":"59","author":"Bhatia","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.drudis.2020.10.009_bib0240","doi-asserted-by":"crossref","first-page":"15532","DOI":"10.1002\/anie.202004832","article-title":"Topology\u2010matching design of an influenza\u2010neutralizing spiky nanoparticle\u2010based inhibitor with a dual mode of action","volume":"59","author":"Nie","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.drudis.2020.10.009_bib0245","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/acs.jmedchem.7b00908","article-title":"Aniline-based inhibitors of influenza H1N1 virus acting on hemagglutinin-mediated fusion","volume":"61","author":"Leiva","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2020.10.009_bib0250","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1016\/j.bmc.2017.06.025","article-title":"Structure-activity relationships of 3-O-\u03b2-chacotriosyl oleanic acid derivatives as entry inhibitors for highly pathogenic H5N1 influenza virus","volume":"25","author":"Li","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2020.10.009_bib0255","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejmech.2016.01.005","article-title":"Design, synthesis and biological evaluation of novel l-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors","volume":"110","author":"Wang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.drudis.2020.10.009_bib0260","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/v8010006","article-title":"Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry","volume":"8","author":"Wu","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2020.10.009_bib0265","article-title":"New influenza a virus entry inhibitors derived from the viral fusion peptides","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2020.10.009_bib0270","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.bbamem.2015.06.015","article-title":"Super short membrane-active lipopeptides inhibiting the entry of influenza A virus","volume":"1848","author":"Wu","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2020.10.009_bib0275","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejmech.2015.02.006","article-title":"Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin","volume":"93","author":"Chen","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.drudis.2020.10.009_bib0280","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/jac\/dkv193","article-title":"6SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential","volume":"70","author":"Sriwilaijaroen","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drudis.2020.10.009_bib0285","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.drudis.2020.10.009_bib0290","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.3389\/fmicb.2018.02660","article-title":"Isolation and characterization of human monoclonal antibodies that recognize the influenza A(H1N1)pdm09 virus hemagglutinin receptor-binding site and rarely yield escape mutant viruses","volume":"9","author":"Yasuhara","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0295","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.50.4.1470-1479.2006","article-title":"Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection","volume":"50","author":"Malakhov","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.009_bib0300","article-title":"Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein","volume":"4","author":"Triana-Baltzer","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2020.10.009_bib0305","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1073\/pnas.1404205111","article-title":"Prevention of influenza by targeting host receptors using engineered proteins","volume":"111","author":"Connaris","year":"2014","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.drudis.2020.10.009_bib0310","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/infdis\/jiy711","article-title":"Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain","volume":"219","author":"Krammer","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0315","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2008.10.009","article-title":"Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol","volume":"81","author":"Leneva","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.drudis.2020.10.009_bib0320","first-page":"84","article-title":"Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A","volume":"77","author":"Leneva","year":"2005","journal-title":"Ter Arkh"},{"key":"10.1016\/j.drudis.2020.10.009_bib0325","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jmv.25358","article-title":"Umifenovir susceptibility monitoring and characterization of influenza viruses isolated during ARBITR clinical study","volume":"91","author":"Leneva","year":"2019","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0330","first-page":"289","article-title":"Efficacy and safety of arbidol in treatment of naturally acquired influenza","volume":"26","author":"Wang","year":"2004","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.drudis.2020.10.009_bib0335","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1073\/pnas.1617020114","article-title":"Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol","volume":"114","author":"Kadam","year":"2017","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.drudis.2020.10.009_bib0340","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00694-18","article-title":"Evaluation of MEDI8852, an anti-influenza a monoclonal antibody, in treating acute uncomplicated influenza","volume":"62","author":"Ali","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.009_bib0345","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40262-017-0564-y","article-title":"Pharmacokinetics of MHAA4549A, an anti-influenza a monoclonal antibody, in healthy subjects challenged with influenza A virus in a phase IIa randomized trial","volume":"57","author":"Deng","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.drudis.2020.10.009_bib0350","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ebiom.2018.12.051","article-title":"Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: results from a randomized, double-blind, phase-2, placebo-controlled study","volume":"40","author":"Hershberger","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drudis.2020.10.009_bib0355","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/CMR.16.2.242-264.2003","article-title":"Parainfluenza viruses","volume":"16","author":"Henrickson","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.drudis.2020.10.009_bib0360","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200106213442507","article-title":"Respiratory syncytial virus and parainfluenza virus","volume":"344","author":"Hall","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2020.10.009_bib0365","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11882-017-0685-2","article-title":"The role of human parainfluenza virus infections in the immunopathology of the respiratory tract","volume":"17","author":"Pawe\u0142czyk","year":"2017","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.drudis.2020.10.009_bib0370","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.virol.2014.07.033","article-title":"Terminal sialic acid linkages determine different cell infectivities of human parainfluenza virus type 1 and type 3","volume":"464\u2013465","author":"Fukushima","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2020.10.009_bib0375","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1128\/JVI.00718-07","article-title":"Human parainfluenza viruses hPIV1 and hPIV3 bind oligosaccharides with \u03b12-3-linked sialic acids that are distinct from those bound by H5 avian influenza virus hemagglutinin","volume":"81","author":"Amonsen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0380","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1586\/ers.11.32","article-title":"Progress in the development of human parainfluenza virus vaccines","volume":"5","author":"Schmidt","year":"2011","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.drudis.2020.10.009_bib0385","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1128\/AAC.48.5.1495-1502.2004","article-title":"Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo","volume":"48","author":"Alymova","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.009_bib0390","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3851\/IMP1420","article-title":"Efficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice \u2013 further evaluation","volume":"14","author":"Alymova","year":"2009","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.drudis.2020.10.009_bib0395","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1128\/AAC.00220-09","article-title":"Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai\/human parainfluenza type 3 chimera virus in mice","volume":"53","author":"Watanabe","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.009_bib0400","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3390\/v11050417","article-title":"Targeting human parainfluenza virus type-1 haemagglutinin-neuraminidase with mechanism-based inhibitors","volume":"11","author":"Eveno","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2020.10.009_bib0405","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02900-18","article-title":"Inhibiting human parainfluenza virus infection by preactivating the cell entry mechanism","volume":"10","author":"Bottom-Tanzer","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.drudis.2020.10.009_bib0410","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03203-19","article-title":"Hijacking the fusion complex of human parainfluenza virus as an antiviral strategy","volume":"11","author":"Marcink","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.drudis.2020.10.009_bib0415","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1556\/EuJMI.4.2014.1.2","article-title":"Human adenovirus: viral pathogen with increasing importance","volume":"4","author":"Ghebremedhin","year":"2014","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0420","series-title":"Viruses and the Lung","first-page":"35","article-title":"Adenovirus","author":"Koirala","year":"2014"},{"key":"10.1016\/j.drudis.2020.10.009_bib0425","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/biomedicines6010030","article-title":"The repertoire of adenovirus in human disease: the innocuous to the deadly","volume":"6","author":"Khanal","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2020.10.009_bib0430","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0166-3542(95)00962-0","article-title":"Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model","volume":"31","author":"De Oliveira","year":"1996","journal-title":"Antiviral Res."},{"key":"10.1016\/j.drudis.2020.10.009_bib0435","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bmt.1702820","article-title":"Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children","volume":"27","author":"Legrand","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.drudis.2020.10.009_bib0440","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/JVI.72.1.415-419.1998","article-title":"The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses","volume":"72","author":"Bergelson","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0445","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/nm952","article-title":"CD46 is a cellular receptor for group B adenoviruses","volume":"9","author":"Gaggar","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2020.10.009_bib0450","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1128\/jvi.68.10.6811-6814.1994","article-title":"Multiple adenovirus serotypes use alpha v integrins for infection","volume":"68","author":"Mathias","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0455","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/rmv.612","article-title":"Adenovirus receptors: implications for tropism, treatment and targeting","volume":"19","author":"Arnberg","year":"2009","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0460","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/JVI.74.1.42-48.2000","article-title":"Adenovirus type 37 uses sialic acid as a cellular receptor","volume":"74","author":"Arnberg","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0465","doi-asserted-by":"crossref","first-page":"7691","DOI":"10.1128\/JVI.74.16.7691-7693.2000","article-title":"Initial interactions of subgenus D adenoviruses with A549 cellular receptors: sialic acid versus alpha(v) integrins","volume":"74","author":"Arnberg","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0470","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/viro.2002.1503","article-title":"Adenovirus type 37 binds to cell surface sialic acid through a charge-dependent interaction","volume":"302","author":"Arnberg","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2020.10.009_bib0475","doi-asserted-by":"crossref","first-page":"48245","DOI":"10.1074\/jbc.M309813200","article-title":"Human-specific regulation of \u03b12-6-linked sialic acids","volume":"278","author":"Gagneux","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2020.10.009_bib0480","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1750-2659.2008.00051.x","article-title":"Sialic acid tissue distribution and influenza virus tropism","volume":"2","author":"Kumlin","year":"2008","journal-title":"Influenza Other Respi. Viruses"},{"key":"10.1016\/j.drudis.2020.10.009_bib0485","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nm.2267","article-title":"The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis","volume":"17","author":"Nilsson","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2020.10.009_bib0490","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cbic.200400227","article-title":"Multivalent HSA conjugates of 3\u2032-sialyllactose are potent inhibitors of adenoviral cell attachment and infection","volume":"6","author":"Johansson","year":"2005","journal-title":"ChemBioChem"},{"key":"10.1016\/j.drudis.2020.10.009_bib0495","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.antiviral.2006.08.004","article-title":"Multivalent sialic acid conjugates inhibit adenovirus type 37 from binding to and infecting human corneal epithelial cells","volume":"73","author":"Johansson","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.drudis.2020.10.009_bib0500","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1002\/anie.201101559","article-title":"A potent trivalent sialic acid inhibitor of adenovirus type 37 infection of human corneal cells","volume":"50","author":"Spjut","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.drudis.2020.10.009_bib0505","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1039\/C5OB01025J","article-title":"Triazole linker-based trivalent sialic acid inhibitors of adenovirus type 37 infection of human corneal epithelial cells","volume":"13","author":"Caraballo","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.drudis.2020.10.009_bib0510","doi-asserted-by":"crossref","first-page":"E4264","DOI":"10.1073\/pnas.1716900115","article-title":"Polysialic acid is a cellular receptor for human adenovirus 52","volume":"115","author":"Lenman","year":"2018","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.drudis.2020.10.009_bib0515","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax3567","article-title":"Human adenovirus type 26 uses sialic acid\u2013bearing glycans as a primary cell entry receptor","volume":"5","author":"Baker","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drudis.2020.10.009_bib0520","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jinf.2013.09.009","article-title":"BK and JC virus: a review","volume":"68","author":"Pinto","year":"2014","journal-title":"J. Infect."},{"key":"10.1016\/j.drudis.2020.10.009_bib0525","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jcv.2009.12.006","article-title":"Human polyoma viruses and disease with emphasis on clinical BK and JC","volume":"47","author":"Boothpur","year":"2010","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0530","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2014.10.013","article-title":"Role of a nuclear localization signal on the minor capsid Proteins VP2 and VP3 in BKPyV nuclear entry","volume":"474","author":"Bennett","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2020.10.009_bib0535","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2018\/e558s","article-title":"Human polyomaviruses and cancer: an overview","volume":"73","author":"Prado","year":"2018","journal-title":"Clinics"},{"key":"10.1016\/j.drudis.2020.10.009_bib0540","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal Integration of a polyomavirus in human Merkel cell carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.drudis.2020.10.009_bib0545","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00018-005-5454-z","article-title":"The human polyomaviruses","volume":"63","author":"Eash","year":"2006","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.drudis.2020.10.009_bib0550","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1681\/ASN.V1051080","article-title":"Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease","volume":"10","author":"Nickeleit","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0555","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.tp.0000269706.59977.a5","article-title":"Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation","volume":"84","author":"Drachenberg","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.drudis.2020.10.009_bib0560","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"9","author":"Tan","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0565","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1086\/344280","article-title":"Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy","volume":"186","author":"Sabath","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0570","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02004-18","article-title":"Infectious entry of Merkel cell polyomavirus","volume":"93","author":"Becker","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0575","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1128\/JVI.72.6.4643-4649.1998","article-title":"Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids","volume":"72","author":"Liu","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0580","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.chom.2010.09.004","article-title":"Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif","volume":"8","author":"Neu","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2020.10.009_bib0585","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1128\/JVI.02123-07","article-title":"Direct correlation between sialic acid binding and infection of cells by two human polyomaviruses (JC virus and BK virus)","volume":"82","author":"Dugan","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0590","doi-asserted-by":"crossref","first-page":"14442","DOI":"10.1128\/JVI.79.22.14442-14445.2005","article-title":"An N-linked glycoprotein with \u03b1(2,3)-linked sialic acid is a receptor for BK virus","volume":"79","author":"Dugan","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002738","article-title":"Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection","volume":"8","author":"Neu","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2020.10.009_bib0600","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1128\/JVI.73.7.5826-5832.1999","article-title":"Discrimination between sialic acid-containing receptors and pseudoreceptors regulates polyomavirus spread in the mouse","volume":"73","author":"Bauer","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0605","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/psc.2731","article-title":"Small-molecule inhibitors of JC polyomavirus infection","volume":"21","author":"Yatawara","year":"2015","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.drudis.2020.10.009_bib0610","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","article-title":"Structural basis for human coronavirus attachment to sialic acid receptors","volume":"26","author":"Tortorici","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0615","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2020.10.009_bib0620","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2020.10.009_bib0625","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses \u2014 drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drudis.2020.10.009_bib0630","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1128\/JVI.00854-15","article-title":"Human coronavirus HKU1 spike protein uses O-acetylated sialic acid as an attachment receptor determinant and employs hemagglutinin-esterase protein as a receptor-destroying enzyme","volume":"89","author":"Huang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0635","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1073\/pnas.85.12.4526","article-title":"Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses","volume":"85","author":"Vlasak","year":"1988","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.drudis.2020.10.009_bib0640","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0300-9084(98)80056-4","article-title":"O-Acetylation of sialic acids","volume":"80","author":"Klein","year":"1998","journal-title":"Biochimie"},{"key":"10.1016\/j.drudis.2020.10.009_bib0645","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/vaccines7040171","article-title":"Post-glycosylation modification of sialic acid and its role in virus pathogenesis","volume":"7","author":"Park","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.drudis.2020.10.009_bib0650","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1073\/pnas.1809667116","article-title":"Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A","volume":"116","author":"Hulswit","year":"2019","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.drudis.2020.10.009_bib0655","doi-asserted-by":"crossref","first-page":"10696","DOI":"10.1073\/pnas.1104306108","article-title":"Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor","volume":"108","author":"Peng","year":"2011","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.drudis.2020.10.009_bib0660","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4580","article-title":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drudis.2020.10.009_bib0665","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2020.10.009_bib0670","doi-asserted-by":"crossref","first-page":"9379","DOI":"10.1128\/JVI.01277-13","article-title":"The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies","volume":"87","author":"Mou","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0675","doi-asserted-by":"crossref","first-page":"E8508","DOI":"10.1073\/pnas.1712592114","article-title":"Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.drudis.2020.10.009_bib0680","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41594-019-0334-7","article-title":"Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors","volume":"26","author":"Park","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0685","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/22221751.2019.1597644","article-title":"Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein","volume":"8","author":"Widjaja","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.drudis.2020.10.009_bib0690","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00705-017-3614-8","article-title":"Picornaviridae-the ever-growing virus family","volume":"163","author":"Zell","year":"2018","journal-title":"Arch. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0695","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.3389\/fmicb.2018.02677","article-title":"Enterovirus D68 \u2013 the new polio?","volume":"9","author":"Cassidy","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0700","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/cid\/ciw372","article-title":"Acute flaccid myelitis in the United States, August\u2013December 2014: results of nationwide surveillance","volume":"63","author":"Sejvar","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0705","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3201\/eid2301.161313","article-title":"Upsurge of enterovirus D68, the Netherlands, 2016","volume":"23","author":"Knoester","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0710","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/S1473-3099(15)00543-5","article-title":"Global emergence of enterovirus D68: a systematic review","volume":"16","author":"Holm-Hansen","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0715","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1016\/S1473-3099(18)30094-X","article-title":"Enterovirus D68 and acute flaccid myelitis\u2014evaluating the evidence for causality","volume":"18","author":"Messacar","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0720","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01954-18","article-title":"Contemporary circulating enterovirus D68 strains have acquired the capacity for viral entry and replication in human neuronal cells","volume":"9","author":"Brown","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.drudis.2020.10.009_bib0725","doi-asserted-by":"crossref","first-page":"8865","DOI":"10.1038\/ncomms9865","article-title":"Sialic acid-dependent cell entry of human enterovirus D68","volume":"6","author":"Liu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drudis.2020.10.009_bib0730","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1128\/JVI.03070-13","article-title":"Antigenic and receptor binding properties of enterovirus 68","volume":"88","author":"Imamura","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0735","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.chom.2016.09.013","article-title":"ICAM-5\/telencephalin is a functional entry receptor for enterovirus D68","volume":"20","author":"Wei","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2020.10.009_bib0740","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1073\/pnas.1524498113","article-title":"Enterovirus D68 receptor requirements unveiled by haploid genetics","volume":"113","author":"Baggen","year":"2016","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.drudis.2020.10.009_bib0745","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1128\/AAC.00766-15","article-title":"In vitro efficacy of antiviral compounds against enterovirus D68","volume":"59","author":"Rhoden","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.009_bib0750","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3201\/eid2207.151990","article-title":"A literature review of Zika virus","volume":"22","author":"Plourde","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0755","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMoa1600651","article-title":"Zika virus associated with microcephaly","volume":"374","author":"Mlakar","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2020.10.009_bib0760","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15585\/mmwr.mm6503e2","article-title":"Possible association between Zika virus infection and microcephaly \u2014 Brazil, 2015","volume":"65","author":"Schuler-Faccini","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.drudis.2020.10.009_bib0765","doi-asserted-by":"crossref","first-page":"S935","DOI":"10.1093\/infdis\/jix515","article-title":"Zika virus structure, maturation, and receptors","volume":"216","author":"Sirohi","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0770","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1128\/JVI.00354-15","article-title":"Biology of Zika virus infection in human skin cells","volume":"89","author":"Hamel","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0775","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/22221751.2019.1590130","article-title":"Cell surface \u03b12,3-linked sialic acid facilitates Zika virus internalization","volume":"8","author":"Tan","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.drudis.2020.10.009_bib0780","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1038\/s41598-018-27224-4","article-title":"The antiviral drug arbidol inhibits Zika virus","volume":"8","author":"Fink","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2020.10.009_bib0785","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.antiviral.2015.09.008","article-title":"Phase 1 clinical trials of DAS181, an inhaled sialidase, in healthy adults","volume":"123","author":"Zenilman","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.drudis.2020.10.009_bib0790","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/infdis\/jis622","article-title":"A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection","volume":"206","author":"Moss","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0795","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1086\/653621","article-title":"A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo","volume":"202","author":"Moscona","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0800","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/ofid\/ofy209.121","article-title":"1715. A randomized, double-blind, placebo-controlled multicenter phase 2 trial to examine the effects of DAS181 in immunocompromised (IC) patients with parainfluenza virus (PIV) lower respiratory tract infection (LRTI) on supplemental oxygen (SO)","volume":"5","author":"Chemaly","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0805","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bbmt.2016.02.011","article-title":"DAS181 for treatment of parainfluenza virus infections in hematopoietic stem cell transplant recipients at a single center","volume":"22","author":"Salvatore","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.drudis.2020.10.009_bib0810","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/430954","article-title":"Influenza virus neuraminidase contributes to secondary bacterial pneumonia","volume":"192","author":"Peltola","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0815","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/421525","article-title":"Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza","volume":"190","author":"McCullers","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0820","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jac\/dkn026","article-title":"Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza","volume":"62","author":"Zhang","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drudis.2020.10.009_bib0825","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/jac\/dkn167","article-title":"Comment on: Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza","volume":"62","author":"Nicholls","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drudis.2020.10.009_bib0830","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jac\/dkn468","article-title":"Influenza virus infection: don\u2019t forget the role of the mucociliary system!","volume":"63","author":"Duez","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drudis.2020.10.009_bib0835","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1086\/651170","article-title":"Sialidase\u2010based anti\u2013influenza virus therapy protects against secondary pneumococcal infection","volume":"201","author":"Hedlund","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0840","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/rmv.372","article-title":"Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding","volume":"13","author":"Matrosovich","year":"2003","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0845","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0954-6111(93)90067-A","article-title":"Airway mucins and their role in defence against micro-organisms","volume":"87","author":"Lamblin","year":"1993","journal-title":"Respir. Med."},{"key":"10.1016\/j.drudis.2020.10.009_bib0850","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1042\/bst0230836","article-title":"Interactions between human respiratory mucins and pathogens","volume":"23","author":"Scharfman","year":"1995","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.drudis.2020.10.009_bib0855","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/infdis\/171.2.335","article-title":"Interactions of surfactant protein A with influenza A viruses: binding and neutralization","volume":"171","author":"Benne","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0860","doi-asserted-by":"crossref","first-page":"L1156","DOI":"10.1152\/ajplung.1997.273.6.L1156","article-title":"Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins","volume":"273","author":"Hartshorn","year":"1997","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0865","doi-asserted-by":"crossref","first-page":"L563","DOI":"10.1152\/ajplung.00280.2001","article-title":"Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection","volume":"282","author":"LeVine","year":"2002","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0870","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.3389\/fimmu.2019.02476","article-title":"Enhanced antiviral activity of human surfactant protein D by site-specific engineering of the carbohydrate recognition domain","volume":"10","author":"van Eijk","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0875","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-3542(02)00020-7","article-title":"Polymeric inhibitor of influenza virus attachment protects mice from experimental influenza infection","volume":"55","author":"Gambaryan","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.drudis.2020.10.009_bib0880","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2005.07.008","article-title":"Polymer-bound 6\u2032 sialyl-N-acetyllactosamine protects mice infected by influenza virus","volume":"68","author":"Gambaryan","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.drudis.2020.10.009_bib0885","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1002\/smll.201001349","article-title":"Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles","volume":"6","author":"Papp","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.drudis.2020.10.009_bib0890","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cbic.201000776","article-title":"Inhibition of influenza virus activity by multivalent glycoarchitectures with matched sizes","volume":"12","author":"Papp","year":"2011","journal-title":"ChemBioChem"},{"key":"10.1016\/j.drudis.2020.10.009_bib0895","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1074\/jbc.M112.437202","article-title":"Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza a virus","volume":"288","author":"Hendricks","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2020.10.009_bib0900","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nnano.2016.181","article-title":"Nanostructured glycan architecture is important in the inhibition of influenza A virus infection","volume":"12","author":"Kwon","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0905","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biomaterials.2017.05.028","article-title":"Linear polysialoside outperforms dendritic analogs for inhibition of influenza virus infection in vitro and in vivo","volume":"138","author":"Bhatia","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2020.10.009_bib0910","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41565-020-0660-2","article-title":"Phage capsid nanoparticles with defined ligand arrangement block influenza virus entry","volume":"15","author":"Lauster","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.drudis.2020.10.009_bib0915","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nmat5053","article-title":"Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism","volume":"17","author":"Cagno","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.drudis.2020.10.009_bib0920","article-title":"Non-toxic virucidal macromolecules show high efficacy against influenza virus ex vivo and in vivo","author":"Kocabiyik","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2020.10.009_bib0925","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1002\/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3","article-title":"Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors","volume":"37","author":"Mammen","year":"1998","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.drudis.2020.10.009_bib0930","doi-asserted-by":"crossref","first-page":"10472","DOI":"10.1002\/anie.201201114","article-title":"Multivalency as a chemical organization and action principle","volume":"51","author":"Fasting","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.drudis.2020.10.009_bib0935","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1021\/acs.nanolett.8b04969","article-title":"Mobility-based quantification of multivalent virus-receptor interactions: new insights into influenza A virus binding mode","volume":"19","author":"M\u00fcller","year":"2019","journal-title":"Nano. Lett."},{"key":"10.1016\/j.drudis.2020.10.009_bib0940","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3762\/bjoc.11.90","article-title":"Influence of length and flexibility of spacers on the binding affinity of divalent ligands","volume":"11","author":"Liese","year":"2015","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.drudis.2020.10.009_bib0945","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/v10040184","article-title":"Arbidol (umifenovir): a broad-spectrum antiviral drug that inhibits medically important arthropod-borne flaviviruses","volume":"10","author":"Haviernik","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2020.10.009_bib0950","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/infdis\/jiu105","article-title":"An investigational antiviral drug, DAS181, effectively inhibits replication of zoonotic influenza a virus subtype H7N9 and protects mice from lethality","volume":"210","author":"Marjuki","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0955","article-title":"Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein","volume":"4","author":"Triana-Baltzer","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2020.10.009_bib0960","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1086\/648378","article-title":"Pre\u2010 and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivir","volume":"200","author":"Koudstaal","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0965","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009106","article-title":"New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets","volume":"5","author":"Friesen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2020.10.009_bib0970","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/092986708784049658","article-title":"Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion","volume":"15","author":"Boriskin","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.drudis.2020.10.009_bib0975","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and function analysis of an antibody recognizing all influenza A subtypes","volume":"166","author":"Kallewaard","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2020.10.009_bib0980","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/infdis\/jix292","article-title":"The hemagglutinin A stem antibody MEDI8852 prevents and controls disease and limits transmission of pandemic influenza viruses","volume":"216","author":"Paules","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.009_bib0985","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.chom.2013.06.004","article-title":"An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies","volume":"14","author":"Nakamura","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2020.10.009_bib0990","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01154-17","article-title":"Phase 2 randomized trial of the safety and efficacy of MHAA4549A, a broadly neutralizing monoclonal antibody, in a human influenza a virus challenge model","volume":"61","author":"McBride","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.009_bib0995","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ebiom.2016.02.021","article-title":"Safety and upper respiratory pharmacokinetics of the hemagglutinin stalk-binding antibody VIS410 support treatment and prophylaxis based on population modeling of seasonal influenza A outbreaks","volume":"5","author":"Wollacott","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drudis.2020.10.009_bib1000","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/AAC.02457-15","article-title":"The hemagglutinin stem-binding monoclonal antibody VIS410 controls influenza virus-induced acute respiratory distress syndrome","volume":"60","author":"Baranovich","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.009_bib1005","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1073\/pnas.1502374112","article-title":"A broadly neutralizing human monoclonal antibody is effective against H7N9","volume":"112","author":"Tharakaraman","year":"2015","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.drudis.2020.10.009_bib1010","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00878-19","article-title":"Novel small molecule targeting the hemagglutinin stalk of influenza viruses","volume":"93","author":"Kim","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.10.009_bib1015","first-page":"363","article-title":"A small-molecule fusion inhibitor of influenza virus is orally active in mice","author":"van Dongen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.drudis.2020.10.009_bib1020","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3389\/fmicb.2018.02643","article-title":"The antihistamine drugs carbinoxamine maleate and chlorpheniramine maleate exhibit potent antiviral activity against a broad spectrum of influenza viruses","volume":"9","author":"Xu","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.drudis.2020.10.009_bib1025","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.chom.2018.04.015","article-title":"A sialylated voltage-dependent Ca2+ channel binds hemagglutinin and mediates influenza A virus entry into mammalian cells","volume":"23","author":"Fujioka","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2020.10.009_bib1030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bcp.2017.07.023","article-title":"Potent influenza A virus entry inhibitors targeting a conserved region of hemagglutinin","volume":"144","author":"Lin","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drudis.2020.10.009_bib1035","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.immuni.2017.03.018","article-title":"An amphibian host defense peptide is virucidal for human H1 hemagglutinin-bearing influenza viruses","volume":"46","author":"Holthausen","year":"2017","journal-title":"Immunity"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620304244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620304244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:52:18Z","timestamp":1761223938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644620304244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":207,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1359644620304244"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2020.10.009","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the development of entry inhibitors for sialic-acid-targeting viruses","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2020.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}